Core needle biopsy (CNB) has emerged as a pivotal diagnostic tool in the evaluation of suspected lymphoma. As a minimally invasive procedure, CNB allows for the extraction of multiple tissue cores ...

Long-term safety and efficacy of bisphosphonate (BP) therapy for more than 24 months (M) in breast cancer (BC) patients (pts) with bone metastasis (BM) No significant financial relationships to ...

This study recruited 65 women of whom 94% were node-positive, and 60% were hormone receptor-negative. The pCR rate was 41.5% and 53.8% for the whole cohort and the hormone receptor–negative subgroup, ...

From a total of 142 studies, six studies remained after reviewing published documents. All six had some evidence of bias, including a lack of initial randomization. The "gold standard" for determining ...

DEAR DR. ROACH: After not having a mammogram for about 10 years, I developed soreness in one breast. I was recently examined by my doctor, and a lump was detected in my breast at “10 o’clock,” about 7 ...

For patients with the most common type of noninvasive breast cancer, routine testing for estrogen and progesterone receptors in tissue taken at the first "needle" biopsy is both unnecessary and ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Initial hormone receptor tests for patients with the most common type of noninvasive breast cancer are not only unnecessary but could be costing U.S. hospitals tens of millions of dollars per year in ...

The word "cancer" alone is enough to send a chill down anyone's spine. When a doctor follows that word with the recommendation for a biopsy, the anxiety often doubles. Though many of us aren't even ...